Takeda Pharmaceutical Company Limited (ADR)

General ticker "TAK" information:

Takeda Pharmaceutical Company Limited (ADR) follows the US Stock Market performance with the rate: 11.3%.

Estimated limits based on current volatility of 0.9%: low 16.10$, high 16.39$

Factors to consider:

Earnings expected soon, date: 2026-01-29 bmo
Company pays dividends (semi-annually): last record date 2025-09-30, amount 0.32$ (Y3.96%)
Total employees count: 49578 as of 2019
Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-03-31 to 2026-03-31

YTD	2022-03-31	2023-03-31	2024-03-31
Operating Revenue	¥3,569,006.00MM	¥4,027,478.00MM	¥4,263,762.00MM
Operating Expenses	¥3,108,162.00MM	¥3,536,973.00MM	¥4,049,687.00MM
Operating Income	¥460,844.00MM	¥490,505.00MM	¥214,075.00MM
Non-Operating Income	¥-158,273.00MM	¥-115,415.00MM	¥-161,284.00MM
Interest Expense	¥122,432.00MM	¥116,973.00MM	¥1,062.44MM
R&D Expense	¥526,087.00MM	¥633,325.00MM	¥729,924.00MM
Income(Loss)	¥302,571.00MM	¥375,090.00MM	¥52,791.00MM
Taxes	¥72,405.00MM	¥58,052.00MM	¥-91,406.00MM
Profit(Loss)*	¥230,059.00MM	¥317,017.00MM	¥144,067.00MM
Stockholders Equity	¥5,683,019.00MM	¥6,354,122.00MM	¥7,273,264.00MM
Inventory	¥853,167.00MM	¥986,457.00MM	¥1,209,869.00MM
Assets	¥13,178,018.00MM	¥13,957,750.00MM	¥15,108,792.00MM
Operating Cash Flow	¥1,123,105.00MM	¥977,156.00MM	¥716,344.00MM
Capital expenditure	¥186,037.00MM	¥633,689.00MM	¥480,730.00MM
Investing Cash Flow	¥-198,125.00MM	¥-607,102.00MM	¥-463,862.00MM
Financing Cash Flow	¥-1,070,265.00MM	¥-709,148.00MM	¥-354,416.00MM
Earnings Per Share**	¥73.57	¥102.14	¥46.04
Ordinary share to ADR	1.00x	1.00x	1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.